Building Toward Antiracist Cancer Research and Practice: The Case of Precision Medicine

Overview

Journal JCO Oncol Pract

Specialty Oncology

Date 2021 May 11

PMID 33974820

Citations 3

Authors

Jacob N Stein

Marjory Charlot

Samuel Cykert

Affiliations

Soon will be listed here.

Citing Articles

Identifying High-Priority Ethical Challenges for Precision Emergency Medicine: Nominal Group Study.

Rose C, Shearer E, Woller I, Foster A, Ashenburg N, Kim I JMIR Form Res. 2025; 9:e68371.

PMID: 39916376 PMC: 11825900. DOI: 10.2196/68371.

Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.

Schuster A, Crossnohere N, Bachini M, Blair C, Carpten J, Claus E Cancer Epidemiol Biomarkers Prev. 2023; 32(4):487-495.

PMID: 36791345 PMC: 10068438. DOI: 10.1158/1055-9965.EPI-22-0356.

Promoting patient engagement in cancer genomics research programs: An environmental scan.

Schuster A, Crossnohere N, Paskett J, Thomas N, Hampel H, Ma Q Front Genet. 2023; 14:1053613.

PMID: 36741312 PMC: 9889863. DOI: 10.3389/fgene.2023.1053613.

Rethinking Patient Engagement in Cancer Research.

Schuster A, Hampel H, Paskett E, Bridges J Patient. 2022; 16(2):89-93.

PMID: 36301439 PMC: 9911482. DOI: 10.1007/s40271-022-00604-9.

References

Lynch J, Berse B, Rabb M, Mosquin P, Chew R, West S . Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013. BMC Cancer. 2018; 18(1):306. PMC: 5859516. DOI: 10.1186/s12885-018-4190-3. View

Bach P, Cramer L, Warren J, Begg C . Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341(16):1198-205. DOI: 10.1056/NEJM199910143411606. View

Howlader N, Forjaz G, Mooradian M, Meza R, Kong C, Cronin K . The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020; 383(7):640-649. PMC: 8577315. DOI: 10.1056/NEJMoa1916623. View

OSullivan B, Huang S, Su J, Garden A, Sturgis E, Dahlstrom K . Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016; 17(4):440-451. DOI: 10.1016/S1470-2045(15)00560-4. View

Wissing M, Kluetz P, Ning Y, Bull J, Merenda C, Murgo A . Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. Cancer. 2014; 120(19):3025-32. DOI: 10.1002/cncr.28809. View

Cargo M, Mercer S . The value and challenges of participatory research: strengthening its practice. Annu Rev Public Health. 2008; 29:325-50. DOI: 10.1146/annurev.publhealth.29.091307.083824. View

Palazzo L, Sheehan D, Tramontano A, Kong C . Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2019; 28(5):926-934. PMC: 6500471. DOI: 10.1158/1055-9965.EPI-18-0917. View

Wallerstein N, Duran B . Using community-based participatory research to address health disparities. Health Promot Pract. 2006; 7(3):312-23. DOI: 10.1177/1524839906289376. View

Kehl K, Lathan C, Johnson B, Schrag D . Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer. J Natl Cancer Inst. 2018; 111(4):431-434. PMC: 6449167. DOI: 10.1093/jnci/djy202. View

10.

Duma N, Idossa D, Durani U, Frank R, Paludo J, Westin G . Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2019; 21(3):e115-e129. DOI: 10.1016/j.cllc.2019.08.005. View

11.

Riaz F, Presley C, Chiang A, Longtine J, Soulos P, Adelson K . Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer. J Geriatr Oncol. 2019; 10(4):669-672. DOI: 10.1016/j.jgo.2019.01.016. View

12.

Mirghani H, Blanchard P . Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?. Clin Transl Radiat Oncol. 2018; 8:4-11. PMC: 5862680. DOI: 10.1016/j.ctro.2017.10.005. View

13.

Cykert S, Eng E, Walker P, Manning M, Robertson L, Arya R . A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med. 2019; 8(3):1095-1102. PMC: 6434214. DOI: 10.1002/cam4.2005. View

14.

Maguire F, Morris C, Parikh-Patel A, Cress R, Keegan T, Li C . Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance. Cancer Epidemiol Biomarkers Prev. 2019; 28(6):1059-1066. DOI: 10.1158/1055-9965.EPI-18-0823. View

15.

Cykert S, Dilworth-Anderson P, Monroe M, Walker P, McGuire F, Corbie-Smith G . Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010; 303(23):2368-76. PMC: 4152904. DOI: 10.1001/jama.2010.793. View

16.

De Las Nueces D, Hacker K, DiGirolamo A, Hicks L . A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. Health Serv Res. 2012; 47(3 Pt 2):1363-86. PMC: 3418827. DOI: 10.1111/j.1475-6773.2012.01386.x. View

17.

Huang F, Mosquera J, Garofalo A, Oh C, Baco M, Amin-Mansour A . Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function Mutations. Cancer Discov. 2017; 7(9):973-983. PMC: 5836784. DOI: 10.1158/2159-8290.CD-16-0960. View

18.

ODonnell P, Dolan M . Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. Clin Cancer Res. 2009; 15(15):4806-14. PMC: 2774468. DOI: 10.1158/1078-0432.CCR-09-0344. View

19.

Soria J, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee K . Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 378(2):113-125. DOI: 10.1056/NEJMoa1713137. View

20.

Rencsok E, Bazzi L, McKay R, Huang F, Friedant A, Vinson J . Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions. Cancer Epidemiol Biomarkers Prev. 2020; 29(7):1374-1380. PMC: 7334076. DOI: 10.1158/1055-9965.EPI-19-1616. View